ABSTRACTObjective: To develop and evaluate floating microspheres of repaglinide (RG).Materials and Methods: RG loaded noneffervescent microspheres of different ratios of ethylcellulose (EC) and hydroxypropyl methylcellulose (HPMCK4M) were prepared using polyvinyl alcohol as emulsifier by solvent evaporation technique. Various process variables such as polymer ratio, stirringspeed, concentration of drug, and emulsifying agent were studied. Compatibility of drug and polymers was studied by Fourier-transform infraredspectroscopy (FTIR). Characterization, in-vitro evaluation, and kinetic studies were performed.Results: FTIR spectra have revealed no drug-excipient incompatibility. The average particle size of microspheres was in the range of 312...
The aim of current work to develop and evaluate sustained release mucoadhesive (SRM) microspheres of...
Objective: To study the stability profile of floating microspheres of repaglinide as per ICH guideli...
Gastro retentive dosage forms have potential for use as controlled-release drug delivery systems. Mu...
The primary objective of the present study was to prepare repaglinide microspheres for the sustained...
The primary objective of the present study was to prepare repaglinide microspheres for the sustained...
The primary objective of the present study was to prepare repaglinide microspheres for the sustained...
The primary objective of the present study was to prepare repaglinide microspheres for the sustained...
Objective: To develop and evaluate floating type gastro-retentive dosage form, appropriate for contr...
Sustained release dosage form is essential for diabetic patients which is marked by continuous thera...
Repaglinide is a potent second generation oral hypoglycaemic agent widely used in treatment of non ...
Repaglinide is a potent second generation oral hypoglycaemic agent widely used in treatment of non ...
Repaglinide is a potent second generation oral hypoglycaemic agent widely used in treatment of non ...
Objective: Current research concerns the expansion of repaglinide matrix floating tablets, which are...
The aim of current work to develop and evaluate sustained release mucoadhesive (SRM) microspheres of...
The aim of current work to develop and evaluate sustained release mucoadhesive (SRM) microspheres of...
The aim of current work to develop and evaluate sustained release mucoadhesive (SRM) microspheres of...
Objective: To study the stability profile of floating microspheres of repaglinide as per ICH guideli...
Gastro retentive dosage forms have potential for use as controlled-release drug delivery systems. Mu...
The primary objective of the present study was to prepare repaglinide microspheres for the sustained...
The primary objective of the present study was to prepare repaglinide microspheres for the sustained...
The primary objective of the present study was to prepare repaglinide microspheres for the sustained...
The primary objective of the present study was to prepare repaglinide microspheres for the sustained...
Objective: To develop and evaluate floating type gastro-retentive dosage form, appropriate for contr...
Sustained release dosage form is essential for diabetic patients which is marked by continuous thera...
Repaglinide is a potent second generation oral hypoglycaemic agent widely used in treatment of non ...
Repaglinide is a potent second generation oral hypoglycaemic agent widely used in treatment of non ...
Repaglinide is a potent second generation oral hypoglycaemic agent widely used in treatment of non ...
Objective: Current research concerns the expansion of repaglinide matrix floating tablets, which are...
The aim of current work to develop and evaluate sustained release mucoadhesive (SRM) microspheres of...
The aim of current work to develop and evaluate sustained release mucoadhesive (SRM) microspheres of...
The aim of current work to develop and evaluate sustained release mucoadhesive (SRM) microspheres of...
Objective: To study the stability profile of floating microspheres of repaglinide as per ICH guideli...
Gastro retentive dosage forms have potential for use as controlled-release drug delivery systems. Mu...